Patents by Inventor Michael Edward John Billingham

Michael Edward John Billingham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
    Publication number: 20040180963
    Abstract: A method of alleviating a fibrotic disease selected from systemic sclerosis, muscular dystrophy and diabetic complications in a warm blooded animal, which comprises administering an effective amount of at least one compound having the formula (I) 1
    Type: Application
    Filed: March 29, 2004
    Publication date: September 16, 2004
    Inventor: Michael Edward John Billingham
  • Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
    Publication number: 20030018077
    Abstract: A method of alleviating psoriasis in a warm blooded animal, which comprises administering an effective amount of at least one compound having the formula (I) 1
    Type: Application
    Filed: May 17, 2002
    Publication date: January 23, 2003
    Inventors: Michael Edward John Billingham, Janet Katherine Fernihough
  • Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
    Patent number: 6414026
    Abstract: A method of alleviating a fibrotic disease selected from lung fibrosis and liver cirrhosis in a warm blooded animal, which comprises administering an effective amount of at least one compound having the formula (I) in which X stands for the oxygen or sulphur atom or for the imino (—NH—) or sulphonyl (—SO2—) radical, Y stands for a direct linkage, or for the oxygen or sulphur atom or for the sulphonyl (—SO2—) radical or for the radical of the formula —CR1R2—, wherein R1 and R2 which may be the same or different are hydrogen, alkyl or aryl radicals or R1 and R2 may be joined together to form a cycloalkyl ring, n is an integer having the value 0 or 1, provided that when n is 0, Y stands for the oxygen or sulphur atom or for the sulphonyl (—SO2—) radical, or an ester, amide or salt thereof.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: July 2, 2002
    Assignee: Arthromics Plc
    Inventor: Michael Edward John Billingham
  • Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
    Publication number: 20020049254
    Abstract: A method of alleviating a fibrotic disease selected from lung fibrosis and liver cirrhosis in a warm blooded animal, which comprises administering an effective amount of at least one compound having the formula (I) 1
    Type: Application
    Filed: November 13, 2001
    Publication date: April 25, 2002
    Inventor: Michael Edward John Billingham
  • Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
    Patent number: 6348497
    Abstract: A method of alleviating loosening of prosthetic joints by administering an effective amount of at least one compound having the formula (I) in which X stands for the oxygen or sulphur atom or for the imino (—NH—) or sulphonyl (—SO2—) radical, Y stands for a direct linkage, or for the oxygen or sulphur atom or for the sulphonyl (—SO2—) radical or for the radical of the formula —CR1R2—, wherein R1 and R2 which may be the same or different are hydrogen, alkyl or aryl radicals or R1 and R2 may be joined together to form a cycloalkyl ring, n is an integer having the value 0 or 1, provided that when n is 0, Y stands for the oxygen or sulphur atom or for the sulphonyl (—SO2—) radical, or an ester, amide or salt thereof.
    Type: Grant
    Filed: November 16, 2000
    Date of Patent: February 19, 2002
    Assignee: Arthromics plc
    Inventor: Michael Edward John Billingham